presenting characteristics as predictors of duration of treatment in sarcoidosis by r.p. baughman,...

6
Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L. Knatterud, and B. Thompson QJM Volume 99(5):307-315 April 24, 2006 © The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Upload: brandon-gallagher

Post on 14-Jan-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L

Presenting characteristics as predictors of duration of treatment in sarcoidosis

by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L. Knatterud, and B. Thompson

QJMVolume 99(5):307-315

April 24, 2006

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Page 2: Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L

Patients in each treatment group vs. predicted vital capacity at initial visit (corrected for self-reported ethnicity).

R.P. Baughman et al. QJM 2006;99:307-315

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Page 3: Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L

Patients in each treatment group vs.

R.P. Baughman et al. QJM 2006;99:307-315

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Page 4: Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L

Patients in each treatment group vs. dyspnoea level at follow-up.

R.P. Baughman et al. QJM 2006;99:307-315

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Page 5: Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L

Patients in each treatment group vs. dyspnoea score at follow-up and self-reported ethnicity (African American vs.

R.P. Baughman et al. QJM 2006;99:307-315

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]

Page 6: Presenting characteristics as predictors of duration of treatment in sarcoidosis by R.P. Baughman, M.A. Judson, A. Teirstein, H. Yeager, M. Rossman, G.L

Therapy at follow up vs. therapy at initial visit.

R.P. Baughman et al. QJM 2006;99:307-315

© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: [email protected]